These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9521415)

  • 1. Extraovarian endometrioid carcinoma associated with unopposed oestrogen replacement therapy.
    Sidhu S; Edwards L; Rainer S; O'Connor T
    Aust N Z J Obstet Gynaecol; 1998 Feb; 38(1):125-7. PubMed ID: 9521415
    [No Abstract]   [Full Text] [Related]  

  • 2. Extraluminal bowel obstruction by endometrioid adenocarcinoma 34 years post-hysterectomy: risks of unopposed oestrogen therapy.
    Wang TT; Jabbour RJ; Girling JC; McDonald PJ
    J R Soc Med; 2011 Oct; 104(10):421-3. PubMed ID: 21969480
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary vaginal endometrioid carcinoma following unopposed estrogen administration.
    Adjetey V; Ganesan R; Downey GP
    J Obstet Gynaecol; 2003 May; 23(3):316-7. PubMed ID: 12918477
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperestrogenism: a relevant risk factor for the development of cancer from endometriosis.
    Zanetta GM; Webb MJ; Li H; Keeney GL
    Gynecol Oncol; 2000 Oct; 79(1):18-22. PubMed ID: 11006024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen-producing, atypically proliferating endometrioid tumor arising in endometriosis.
    Powell JL; Connor GP; Henderson GS
    South Med J; 2001 Apr; 94(4):450-3. PubMed ID: 11332919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrioid adenocarcinoma arising from endometriosis of the mesenterium of the sigmoid colon.
    Kawate S; Takeyoshi I; Ikota H; Numaga Y; Sunose Y; Morishita Y
    Jpn J Clin Oncol; 2005 Mar; 35(3):154-7. PubMed ID: 15741306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometriosis-associated intestinal tumours: a consequence of long-term unopposed oestrogen?
    Efthymiou CA
    Ann R Coll Surg Engl; 2009 Apr; 91(3):259-60. PubMed ID: 19220946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignancy arising in endometriosis associated with unopposed estrogen replacement.
    Reimnitz C; Brand E; Nieberg RK; Hacker NF
    Obstet Gynecol; 1988 Mar; 71(3 Pt 2):444-7. PubMed ID: 3279356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrioid carcinoma arising from endometriosis of the sigmoid colon during estrogenic treatment.
    Duun S; Roed-Petersen K; Michelsen JW
    Acta Obstet Gynecol Scand; 1993 Nov; 72(8):676-8. PubMed ID: 8259757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrioid adenocarcinoma 13 years after total abdominal hysterectomy and bilateral salpingo-oophorectomy.
    Al-Talib A; Gilbert L; Arseneau J
    Saudi Med J; 2008 Jul; 29(7):1044-7. PubMed ID: 18626539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrioid adenocarcinoma arising from endometriosis during 2 years of estrogen replacement therapy after total hysterectomy and bilateral salpingo-oophorectomy.
    Nomura S; Suganuma T; Suzuki T; Ito T; Kajiyama H; Okada M; Shibata K; Ino K; Kikkawa F; Mizutani S
    Acta Obstet Gynecol Scand; 2006; 85(8):1019-21. PubMed ID: 16862489
    [No Abstract]   [Full Text] [Related]  

  • 12. Which is the appropriate hormone replacement therapy after sub-total hysterectomy?
    Imoh-Ita F; Morgan P; Rymer J
    Climacteric; 2000 Mar; 3(1):65-7. PubMed ID: 11910612
    [No Abstract]   [Full Text] [Related]  

  • 13. Estrogen-induced panic disorder.
    Dembert ML; Dinneen MP; Opsahl MS
    Am J Psychiatry; 1994 Aug; 151(8):1246. PubMed ID: 8037264
    [No Abstract]   [Full Text] [Related]  

  • 14. Malignancy arising in extraovarian endometriosis during estrogen stimulation.
    Gücer F; Pieber D; Arikan MG
    Eur J Gynaecol Oncol; 1998; 19(1):39-41. PubMed ID: 9476057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignancy arising in residual endometriosis following hysterectomy and hormone replacement therapy.
    Soliman NF; Evans AJ
    J Br Menopause Soc; 2004 Sep; 10(3):123-4. PubMed ID: 15494105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy and risk of epithelial ovarian cancer.
    Purdie DM; Bain CJ; Siskind V; Russell P; Hacker NF; Ward BG; Quinn MA; Green AC
    Br J Cancer; 1999 Oct; 81(3):559-63. PubMed ID: 10507786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal endometrioma and hormonal replacement therapy.
    Goh JT; Hall BA
    Aust N Z J Obstet Gynaecol; 1992 Nov; 32(4):384-5. PubMed ID: 1337826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral ureteric obstruction due to recurrent endometriosis associated with hormone replacement therapy.
    Lam AM; French M; Charnock FM
    Aust N Z J Obstet Gynaecol; 1992 Feb; 32(1):83-4. PubMed ID: 1586345
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovariectomy.
    Kalyan S; Hitchcock CL; Sirrs S; Pudek M; Prior JC
    Pharmacotherapy; 2010 May; 30(5):442-52. PubMed ID: 20411996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant degeneration in women operated on for endometriosis].
    Ivanov S; Ivanov S
    Akush Ginekol (Sofiia); 1998; 37(3):29-30. PubMed ID: 10204263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.